Abstract:Tumor behavior, including its response to treatments, is influenced by interactions between mesenchymal and malignant cells, as well as their spatial arrangement. To study tumor biology and evaluate anticancer drugs, accurate 3D tumor models are essential. Here, we developed an in vitro biomimetic hepatoma microenvironment model by combining an extracellular matrix (3DM-7721). Initially, the internal grid structure, composed of 10/6 % GelMA/gelatin loaded with SMMC-7721 cells, was printed using 3D bioprinting. The external component consisted of fibroblasts and human umbilical vein endothelial cells loaded with 10/3 % GelMA/gelatin. A control model (3DP-7721) lacked external cell loading. GelMA/gelatin hydrogels provided robust structural support and biocompatibility. The SMMC-7721 cells in the 3DM-7721 model exhibit superior tumor-associated gene expression and proliferation characteristics when compared to the 3DP-7721 model. Furthermore, the 3DM-7721 type exhibited increased resistance to anticancer agents. SMMC-7721 cells in the 3DM-7721 model exhibit significant tumorigenicity in nude mice. The 3DM-7721 model group showed pathological characteristics of malignant tumors, with a high degree of deterioration, and a significant positive correlation between malignant tumor-related gene pathways. This high-fidelity 3DM-7721 tumor microenvironment model is invaluable for studying tumor progression, devising effective treatment strategies, and discovering drugs. Statement of significance 1. A hepatoma microenvironment model (3DM-7721) incorporating an extracellular matrix that is designed to establish solid tumor models in vitro . 2. This model contains a 3D-printed internal tumor component of liver cancer cells loaded with 10/6 % gelatin methacrylate (GelMA)/gelatin (the 3DP-7721 model) and an external extracellular-matrix component of fibroblasts and human umbilical vein endothelial cells loaded with 10/3 % GelMA/gelatin. 3. The 3DM-7721 model outperforms the 3DP-7721 model in terms of the SMMC-7721 cell proliferation characteristics and tumorigenicity, tumor-related gene expression, anticancer drug resistance, and malignant tumor characteristics.

Satellite‐based On‐orbit Printing of 3d Tumor Models

3D Bioprinting Tumor Models Mimic the Tumor Microenvironment for Drug Screening

Bioprinting of Novel 3D Tumor Array Chip for Drug Screening

3D Bioprinting in Microgravity: Opportunities, Challenges, and Possible Applications in Space

Advances in tumor microenvironment: Applications and challenges of 3D bioprinting

3D bioprinting of an in vitro hepatoma microenvironment model: Establishment, evaluation, and anticancer drug testing

3D Tumor Model Biofabrication

Bioprinted, spatially defined breast tumor microenvironment models of intratumoral heterogeneity and drug resistance

3D Bioprinted Hyaluronic Acid-Based Cell-Laden Scaffold for Brain Microenvironment Simulation

A 3D bioprinted tumor model fabricated with gelatin/sodium alginate/decellularized extracellular matrix bioink

The acoustic droplet printing of functional tumor microenvironments

3D bioprinting platform development for high-throughput cancer organoid models construction and drug evaluation

Improving Bioprinted Volumetric Tumor Microenvironments In Vitro

Embedded Bioprinting of Breast Tumor Cells and Organoids Using Low Concentration Collagen Based Bioinks

Mimicking tumor microenvironment by 3D bioprinting: 3D cancer modeling

The Prospects for Bioprinting Tumor Models: Recent Advances in Their Applications

Three-dimensional bio-printing: A new frontier in oncology research

Polysaccharide hydrogel based 3D printed tumor models for chemotherapeutic drug screening

3D bioprinted tumor model: a prompt and convenient platform for overcoming immunotherapy resistance by recapitulating the tumor microenvironment

Three-Dimensional (3D) Printing in Cancer Therapy and Diagnostics: Current Status and Future Perspectives

3D Bioprinting as a Powerful Technique for Recreating the Tumor Microenvironment